Home Our Groups We firmly believe in sharing knowledge. From experienced veterans to talented young researchers, we work together in 62 groups. AMOLF Kristina Ganzinger Group Single-molecule imaging of immune receptor organisation & immune cell membrane models NKI Wilbert Zwart Group Hormones and Cancer Sanquin Monika Wolkers Group T cell effector function, post-transcriptional gene regulation, RNA binding proteins NKI Lodewyk Wessels Group Computational Biology NKI Emile Voest Group Genomics, precision medicine, organoids, immunotherapy NKI Karin de Visser Group Inflammation and cancer Amsterdam UMC Louis Vermeulen Group Cancer molecular subtypes, stem cell dynamics, colorectal cancer, microenvironment Radboud University Michiel Vermeulen Group Proteomics & Chromatin biology Princess Máxima Center Sebastiaan van Heesch Group Microprotein biology and immunotherapy target discovery in childhood cancer NKI Daniela Thommen Group Precision cancer immunotherapy Hubrecht Institute Marvin Tanenbaum Group Single molecule analysis of gene expression dynamics Leiden University Mario van der Stelt Group Medicinal chemistry, drug discovery, chemical biology NKI Bas van Steensel Group Genome Biology and Gene Regulation Erasmus MC Nitika Taneja Group 3-D chromatin remodeling and replication Princess Máxima Center Hugo Snippert Group Functional heterogeneity in cancer NKI Titia Sixma Group Structural Biology NKI Ton Schumacher Group Molecular Oncology & Immunology Erasmus MC Rebekka Schneider Group Hematopoietic stem cells; leukemia; bone marrow failure; myelodysplastic syndrome; myeloproliferative neoplasms; genetic fate tracing; CRISPR-Cas9; scRNA sequencing Hubrecht Institute Danny Sahtoe Group Protein Design UMC Utrecht Maria Rodriguez Colman Group Metabolism, Cancer and Stem Cells Princess Máxima Center Anne Rios Group Cancer, immunotherapy development, high resolution 3D imaging, organoid technology, bio-engineering UMC Utrecht Jeroen de Ridder Group Bioinformatics, Machine learning and AI, Nanopore Sequencing NKI Jacco van Rheenen Group Intravital Microscopy Leiden University Sebastian Pomplun Group Drug discovery – Novel chemical modalities – Nucleic acid binding proteins NKI Anastassis Perrakis Group Structural Biology, Cell Division, Lysolipid Signalling NKI Daniel Peeper Group Functional genomics for rational tumor and immune cell combination therapy Hubrecht Institute Hans Clevers Group Adult Stem cells and cancer Hubrecht Institute Alexander van Oudenaarden Group Quantitative biology of development & stem cells LUMC Sylvie Noordermeer Group DNA damage repair, homologous recombination, BRCA1 LUMC Jacques Neefjes Group Cell biology, infection, cancer and cancer drugs UMC Utrecht Linde Meyaard Group Infection & immunity Princess Máxima Center René Medema Group Cell Division and Cancer Amsterdam UMC Jan Paul Medema Group Experimental Oncology and Radiobiology UMC Utrecht Madelon Maurice Group Mechanisms of cell-cell communication and tissue self-organization Erasmus MC Jurgen Marteijn Group Transcription Stress & Genome Stability Radboud UMC Geert Litjens Group Applications of AI in oncology NKI Tineke Lenstra Group Transcription dynamics, single-molecule imaging UMC Utrecht Susanne Lens Group Genome instability UMC Utrecht Wouter de Laat Group Biomedical genomics Hubrecht Institute Geert Kops Group Cell division & chromosome segregation Hubrecht Institute Puck Knipscheer Group Molecular mechanisms and regulation of DNA repair Hubrecht Institute Jop Kind Group Spatiotemporal regulation of genomic function Erasmus MC Roland Kanaar Group Molecular radiation biology NKI Jos Jonkers Group Mouse models of breast cancer Princess Máxima Center Jan Hoeijmakers Group DNA repair Leiden University Laura Heitman Group GPCR, allosteric modulation, target binding kinetics, small molecule Radboud University Maike Hansen Group Single Cell Analysis, Cell Fate Decisions Amsterdam UMC Joep Grootjans Group The role of the immune system in cancer development and progression UMCG Lude Franke Group Functional genomics Radboud UMC Carl Figdor Group Chemical Immunology, antigen presenting cells, Immunotherapy Princess Máxima Center Jarno Drost Group Molecular dissection of childhood solid tumors LUMC Peter ten Dijke Group Chemical Signaling Amsterdam UMC Sarah Derks Group GEA, genome-immunome interactions, intratumor heterogeneity, targeted-immunotherapy Erasmus MC Ruud Delwel Group Molecular genetics of AML Erasmus MC Miao-Ping Chien Group Single cell technology, advanced imaging & quantitative analysis, cancer-driving cells, target discovery UMC Utrecht Boudewijn Burgering Group Signal transduction and metabolism LUMC Sjoerd van der Burg Group Immunotherapy; T-cells; immune regulation; clinical trials NKI Thijn Brummelkamp Group Experimental biomedical genetics Princess Máxima Center Ruben van Boxtel Group Cancer Etiology, Mutagenesis and Clonal Evolution NKI René Bernards Group Functional Cancer Genetics NKI Reuven Agami Group Controlling cancer by RNA NKI Leila Akkari Group Immune cells and macrophages in therapeutically challenging tumors
AMOLF Kristina Ganzinger Group Single-molecule imaging of immune receptor organisation & immune cell membrane models
Sanquin Monika Wolkers Group T cell effector function, post-transcriptional gene regulation, RNA binding proteins
Amsterdam UMC Louis Vermeulen Group Cancer molecular subtypes, stem cell dynamics, colorectal cancer, microenvironment
Princess Máxima Center Sebastiaan van Heesch Group Microprotein biology and immunotherapy target discovery in childhood cancer
Erasmus MC Rebekka Schneider Group Hematopoietic stem cells; leukemia; bone marrow failure; myelodysplastic syndrome; myeloproliferative neoplasms; genetic fate tracing; CRISPR-Cas9; scRNA sequencing
Princess Máxima Center Anne Rios Group Cancer, immunotherapy development, high resolution 3D imaging, organoid technology, bio-engineering
Leiden University Sebastian Pomplun Group Drug discovery – Novel chemical modalities – Nucleic acid binding proteins
Leiden University Laura Heitman Group GPCR, allosteric modulation, target binding kinetics, small molecule
Amsterdam UMC Joep Grootjans Group The role of the immune system in cancer development and progression
Amsterdam UMC Sarah Derks Group GEA, genome-immunome interactions, intratumor heterogeneity, targeted-immunotherapy
Erasmus MC Miao-Ping Chien Group Single cell technology, advanced imaging & quantitative analysis, cancer-driving cells, target discovery
